Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer Mammen

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Arthritis Research & Therapy|April 1, 2025
Higher levels of VEGF-A and TNFα in patients with immune checkpoint inhibitor-induced inflammatory arthritisElise F Gray-Gaillard, Ami A Shah, Clifton O Bingham Iii, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 13, 2025
It Is Personal: What People with Parkinson's Disease Say Matters Most for Quality of LifeSamantha Dorrance, Richa Patel, Glenn T Stebbins, et al.
Movement Disorders Clinical Practice|January 10, 2026
Defining Quality of Life: The Perspective of People Living with Parkinson's DiseaseSamantha Dorrance, Richa Patel, Glenn T Stebbins, et al.
The Journal of Clinical Investigation|July 17, 2019
The alveolar immune cell landscape is dysregulated in checkpoint inhibitor pneumonitisKarthik Suresh, Jarushka Naidoo, Qiong Zhong, et al.
NPJ Parkinson'S Disease|November 20, 2024
Accelerating Parkinson's Disease drug development with federated learning approachesAmit Khanna, Jamie Adams, Chrystalina Antoniades, et al.
Journal for Immunotherapy of Cancer|October 15, 2025
Consensus-based disease definitions for endocrine immune-related adverse events of immune checkpoint inhibitorsLing Zhu, Yee-Ming M Cheung, Cherie Chiang, et al.
The Lancet. Diabetes & Endocrinology|April 30, 2026
Natural history of thyroid function in ageing: an individual participant data analysis of 137 488 participants from 31 prospective cohort studiesYanning Xu, Ola Hysaj, Xiaoyi Qi, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Arthritis Research & Therapy|April 1, 2025
Higher levels of VEGF-A and TNFα in patients with immune checkpoint inhibitor-induced inflammatory arthritisElise F Gray-Gaillard, Ami A Shah, Clifton O Bingham Iii, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 13, 2025
It Is Personal: What People with Parkinson's Disease Say Matters Most for Quality of LifeSamantha Dorrance, Richa Patel, Glenn T Stebbins, et al.
Movement Disorders Clinical Practice|January 10, 2026
Defining Quality of Life: The Perspective of People Living with Parkinson's DiseaseSamantha Dorrance, Richa Patel, Glenn T Stebbins, et al.
The Journal of Clinical Investigation|July 17, 2019
The alveolar immune cell landscape is dysregulated in checkpoint inhibitor pneumonitisKarthik Suresh, Jarushka Naidoo, Qiong Zhong, et al.
NPJ Parkinson'S Disease|November 20, 2024
Accelerating Parkinson's Disease drug development with federated learning approachesAmit Khanna, Jamie Adams, Chrystalina Antoniades, et al.
Journal for Immunotherapy of Cancer|October 15, 2025
Consensus-based disease definitions for endocrine immune-related adverse events of immune checkpoint inhibitorsLing Zhu, Yee-Ming M Cheung, Cherie Chiang, et al.
The Lancet. Diabetes & Endocrinology|April 30, 2026
Natural history of thyroid function in ageing: an individual participant data analysis of 137 488 participants from 31 prospective cohort studiesYanning Xu, Ola Hysaj, Xiaoyi Qi, et al.
Pageof 2